MANCARELLA, CATERINA
 Distribuzione geografica
Continente #
EU - Europa 363
NA - Nord America 346
AS - Asia 144
AF - Africa 14
SA - Sud America 2
OC - Oceania 1
Totale 870
Nazione #
US - Stati Uniti d'America 344
IT - Italia 137
DE - Germania 66
GB - Regno Unito 46
SG - Singapore 45
VN - Vietnam 40
SE - Svezia 36
CN - Cina 35
CH - Svizzera 26
IE - Irlanda 14
IN - India 11
FR - Francia 10
BG - Bulgaria 9
RU - Federazione Russa 7
TG - Togo 7
ID - Indonesia 5
JO - Giordania 4
EE - Estonia 3
NL - Olanda 3
ZA - Sudafrica 3
CA - Canada 2
CI - Costa d'Avorio 2
NG - Nigeria 2
PK - Pakistan 2
UA - Ucraina 2
AT - Austria 1
AU - Australia 1
BE - Belgio 1
CL - Cile 1
GR - Grecia 1
HK - Hong Kong 1
PE - Perù 1
PL - Polonia 1
TH - Thailandia 1
Totale 870
Città #
Fairfield 43
Chandler 42
Southend 41
Singapore 38
Frankfurt am Main 34
Bologna 28
Bern 26
Ashburn 22
Ann Arbor 20
Dong Ket 20
Cambridge 19
Santa Clara 15
Woodbridge 15
Dublin 14
Florence 14
Princeton 12
Seattle 12
Wilmington 12
Boardman 9
Houston 9
Sofia 9
Bremen 7
Lomé 7
New York 7
Turin 6
Jakarta 5
Nanjing 5
Amman 4
Beijing 4
Berlin 4
Rome 4
Boydton 3
Francavilla Al Mare 3
Guangzhou 3
Jinan 3
Los Angeles 3
Milan 3
Paris 3
Parma 3
Reggio Emilia 3
Reggio Nell'emilia 3
Shenyang 3
Westminster 3
Abeokuta 2
Abidjan 2
Amsterdam 2
Bellaria-Igea Marina 2
Cagliari 2
Fusignano 2
Giavera del Montello 2
Lahore 2
London 2
Modena 2
Munich 2
Mülheim 2
Naples 2
Norwalk 2
Padova 2
Ravenna 2
San Diego 2
San Gavino Monreale 2
Siderno 2
Siena 2
Verona 2
Ancona 1
Bruges 1
Bühl 1
Caserta 1
Castenaso 1
Changchun 1
Chengdu 1
Chincha Alta 1
Crocetta 1
Des Moines 1
Hangzhou 1
Hebei 1
Hounslow 1
Hyderabad 1
Jiaxing 1
Medford 1
Montesarchio 1
Ningbo 1
Phoenix 1
Richmond 1
Riva 1
Saint Petersburg 1
Saint-Gely-du-Fesc 1
San Jose 1
San Pietro In Casale 1
Serio 1
Taizhou 1
Tianjin 1
Vanderhoof 1
Vienna 1
Wanchai 1
Warsaw 1
Wenzhou 1
Wuxi 1
Zhangjiagang 1
Totale 620
Nome #
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma 169
Insulin-like growth factor 2 mRNA-binding protein 3 is a novel post-transcriptional regulator of Ewing sarcoma malignancy 125
Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug. 124
Abstract 3201: Insulin-like growth factor 2 (IGF-2) mRNA binding protein 3 predicts poor prognosis and promotes cell proliferation in Ewing sarcoma 122
Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma 110
Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis 84
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis 59
Polymorphic variants of IGF2BP3 and SENCR have an impact on predisposition and/or progression of Ewing sarcoma 58
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis 50
Totale 901
Categoria #
all - tutte 2.905
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.905


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202079 0 0 0 0 0 13 15 16 21 7 6 1
2020/202176 12 0 2 8 0 4 0 4 11 4 0 31
2021/2022169 25 0 4 2 10 5 1 21 15 19 45 22
2022/2023297 17 23 12 39 25 25 10 16 38 9 45 38
2023/2024108 9 22 10 13 9 18 5 8 4 5 0 5
2024/2025111 18 28 17 25 23 0 0 0 0 0 0 0
Totale 901